Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 211 Results July 31, 2017 American Journal of Psychiatry Publishes Minerva Neurosciences’ MIN-101 Phase 2b Trial Results for Treatment of Negative Symptoms in Schizophrenia July 27, 2017 Minerva Neurosciences to Report Second Quarter 2017 Financial Results and Business Updates on August 3, 2017 July 24, 2017 Minerva Neurosciences Announces Departure of Directors July 5, 2017 Minerva Neurosciences Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares June 28, 2017 Minerva Neurosciences Announces Pricing of Public Offering of Common Stock June 27, 2017 Minerva Neurosciences, Inc. to Offer Common Shares June 22, 2017 Minerva Announces Completion of Bridging Study to Select Improved Formulation of MIN-101 for Use in Phase 3 Trial for the Treatment of Negative Symptoms in Patients With Schizophrenia May 31, 2017 Minerva Announces Amended Agreement for MIN-202 in Insomnia May 30, 2017 Minerva Neurosciences to Present at Jefferies 2017 Healthcare Conference on June 6, 2017 May 15, 2017 Minerva Announces Outcome of End-of-Phase 2 Meeting With FDA «...1213141516...20...»